Peer Review History
| Original SubmissionJuly 13, 2021 |
|---|
|
PONE-D-21-20569 Clinician motivation in shared decision-making implementation: A qualitative study PLOS ONE Dear Dr. Fijten, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 01 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Chaisiri Angkurawaranon Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide the interview guide used. 3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 4. Thank you for stating the following in the Funding Section of your manuscript: “This study was funded by the ESTRO Technology Transfer Grant (TTG).”. We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Funding section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “This study was supported by a Technology Transfer Grant (TTG) from the European Society for Radiotherapy and Oncology (ESTRO - www.estro.org). AA was the recipient of this mobility grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”. Please include your amended statements within your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is a well-written and interesting manuscript on clinicians’ experiences with implementing SDM within a hospital setting that is known for successful use of SDM in routine practice. I have two primary concerns with this manuscript. First, the purpose/focus of the study appears to change throughout the manuscript and is thus unclear. At times, it seems that the authors are interested in learning about clinicians’ experience of the implementation process (e.g., descriptive accounts of the SDM training and PDA development process), while at others it appears that the authors are specifically focused on perceived barriers and facilitators to SDM implementation. Further, the title of the manuscript leads one to believe that the focus is on factors that motivate clinicians to implement SDM, which is not consistent with the more comprehensive focus of the manuscript. The authors should further clarify the purpose of the study and ensure that it remains consistent throughout. Second, themes derived from the data are briefly mentioned in the results section, but not elaborated upon in a coherent way. After mention of the themes, results are organized according to experiences at various stages of the implementation process rather than by theme. Further, Figure 1 does not appear to map on to any of the named themes. This makes evaluation of how themes were derived and what data support them difficult. The authors might consider a re-organization of the results section to better elucidate themes. Additional comments on specific sections of the manuscript are below. Abstract: The abstract should clearly describe all themes that were derived from the data. Methods: Citations are needed when referencing specific methods (e.g., thematic analysis). How was it determined that participants had the relevant experience with SDM implementation in order to participate effectively in the interviews? Was the decision to include both those who had undergone SDM training and those in leadership strategic (i.e., part of the purposive sampling strategy)? p. 11 (lines 177-181): This paragraph is unclear. Were only open codes compared? Or both open and axial codes? How were open codes further categorized and who performed this step? Results: For context, it would be helpful if the SDM training were described in greater detail. For instance, what SDM model was this training based on? Reviewer #2: Review report Manuscript Number: PONE-D-21-20569 Manuscript Title: Clinician motivation in shared decision-making implementation: A qualitative study This manuscript addresses an important theme and is well written. The relevance for this study to the practice field is high. A major revision is needed regarding the analysis and presentation of the results, in addition to some minor revisions. I do believe that this can become a good contribution to the field. Abstract and introduction 1) Abstract p.2: “The goal was to identify implementation barriers, strategies used to address them, and remaining challenges.” Introduction p.6: ” The aim of this study, therefore, is to gain insight into how clinicians at Vejle Hospital experience the introduction of a SDM initiative into their workflow, the training process, and the impact on their daily practice.” Discussion p.20: “The purpose of this qualitative study was to examine practitioners’ experiences of the Center’s efforts to introduce SDM and PDAs into clinical practice.” The aim/ goal/purpose of the study should be consistent throughout the manuscript. 2) The research question should be reported. Methods 3) I recommend the authors to give the description of the authors’ contribution under each related section, for example “The interviews were conducted by AA..” could preferable have been described under the heading data collection. “Participants were recruited by means of purposive sampling [16] and were identified through KDS..” is related to study population and could preferable have been described under this heading. Ethical guidelines: 4) The contribution of the authors AA, KDS and HH is described but the role of the other authors is unknown. What was their contribution in this study? This is important to describe according to the Vancouver recommendations. 5) Anonymization of the participants is important in research and the authors should outline how anonymity is facilitated. Data collection: 6) The interview guide is presented with two themes numbered 5. 7) Please report who transcribed the interviews. 8) The authors report a study consisting of semi-structured interviews. This design is not compatible with “observations were recorded as field notes” (p.11). If the field notes are included in the data material in addition to the interviews the study design should be revised. Analysis: 9) Please include a reference to thematic analysis method. 10) It is unclear how the field notes were analysed. Did the author mix the two different data sets, the interviews and the field notes? Can the authors elaborate this? 11) Please elaborate what the interpretations were based on. 12) The last section in “Data analysis” focuses on the interviews and should be moved to related section (data collection). Results, discussion, conclusions 13) The quote on p.16 is not identified (participant no.) 14) It is unclear if the results reflect the data material (the participants’ answers of the 6 themes in the interview guide). The aim of this study was to gain insight into how clinicians at Vejle Hospital experience the introduction of a SDM initiative into their workflow, the training process, and the impact on their daily practice. Only “The challenges encountered by our participants at each phase and the strategies they used to address them are summarized in Figure 1 and elaborated below” (p.12) are presented as results. The authors are advised to look at the entire data material in light of the research question (which must be presented in the manuscript) and make an analysis were the results reflect the whole data material and the aim of the study. 15) Figure 1 presents an overview of challenges to SDM implementation and strategies to overcome them at different phases of implementation. It is unclear if these items are the themes, categories and codes. The authors are encouraged to provide a description of the coding tree. There should be clarity of themes were the themes are clearly presented in the results and clarity of categories and codes with a description of diverse cases or discussion of these in the results. 16) The conclusion should answer the aim and research question and must be reconsidered. 17) The patient perspective is the onus of SDM. This study reflects only the clinicians’ perspective and should have been reported as a limitation and discussed. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Lise Sæstad Beyene [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Practitioners’ views on shared decision-making implementation: A qualitative study PONE-D-21-20569R1 Dear Dr. Fijten, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Chaisiri Angkurawaranon Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No |
| Formally Accepted |
|
PONE-D-21-20569R1 Practitioners’ views on shared decision-making implementation: A qualitative study Dear Dr. Fijten: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Chaisiri Angkurawaranon Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .